PIK3CA and ductal breast carcinoma in situ: Finally, among relapse tumors, distant metastases and contralateral tumors without DCIS showed a significantly higher frequency of PIK3CA mutations (p = 0.037; Supplementary Table S1 and Supplementary Fig. S4).